Grant Details
| Grant Number: | 3R01CA071358-04S1 Interpret this number |
| Primary Investigator: | Swan, Gary |
| Organization: | Sri International |
| Project Title: | Treatment of Nicotine Dependence in an Hmo Setting |
| Fiscal Year: | 2002 |
Abstract
An abstract does not currently exist for this grant
Publications
Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial.
Authors: McClure JB, Jack L, Deprey M, Catz S, McAfee T, Zbikowski S, Westbrook E, Swan G
Source: Nicotine Tob Res, 2008 Dec;10(12), p. 1815-6.
PMID: 19023832
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation.
Authors: Swan GE, Jack LM, Javitz HS, McAfee T, McClure JB
Source: CNS Drugs, 2008;22(3), p. 239-56.
PMID: 18278978
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.
Authors: Swan GE, Jack LM, Valdes AM, Ring HZ, Ton CC, Curry SJ, McAfee T
Source: Health Psychol, 2007 May;26(3), p. 361-8.
PMID: 17500623
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
Tailoring nicotine replacement therapy: rationale and potential approaches.
Authors: McClure JB, Swan GE
Source: CNS Drugs, 2006;20(4), p. 281-91.
PMID: 16599646
Related Citations
Grant Numbers:
| NCI NIH HHS - 2 R01 CA71358 | NCI NIH HHS - R01 CA100341 |
MeSH Terms:
| Drug Delivery Systems | Animals | Nicotine |
| Drug Eruptions | Tobacco Use Disorder | Nicotinic Agonists |
| Humans | Smoking Cessation |
Financial burden of tobacco use: an employer's perspective.
Authors: Javitz HS, Zbikowski SM, Swan GE, Jack LM
Source: Clin Occup Environ Med, 2006;5(1), p. 9-29, vii.
PMID: 16446251
Related Citations
Grant Numbers:
| NCI NIH HHS - R01-CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
| Occupational Exposure | Smoking | Pensions |
| Air Pollution, Indoor | Tobacco Use Disorder | Humans |
| Employer Health Costs | Workplace | Retirement |
Smoking cessation treatment: pharmacogenetic assessment.
Authors: Munafò MR, Lerman C, Niaura R, Shields AE, Swan GE
Source: Curr Opin Mol Ther, 2005 Jun;7(3), p. 202-8.
PMID: 15977416
Related Citations
Grant Numbers:
| NIDA NIH HHS - DA11170 | PHS HHS - P50 84718 | NCI NIH HHS - CA71358 |
| NCI NIH HHS - P50 CA84719 |
MeSH Terms:
| Genotype | Tobacco Use Disorder | Humans |
| Smoking Cessation | Pharmacogenetics |
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.
Authors: Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC, Curry SJ, McAfee T
Source: Pharmacogenomics J, 2005;5(1), p. 21-9.
PMID: 15492764
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
| Genotype | Smoking | Receptors, Dopamine D2 |
| Humans | Smoking Cessation | Bupropion |
| Adult | Treatment Outcome | Middle Aged |
| Follow-Up Studies | Male | Female |
Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective.
Authors: Javitz HS, Swan GE, Zbikowski SM, Curry SJ, McAfee TA, Decker D, Patterson R, Jack LM
Source: Value Health, 2004 Sep-Oct;7(5), p. 535-43.
PMID: 15367249
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
| Washington | Delayed-Action Preparations | Behavior Therapy |
| Humans | Cost-Benefit Analysis | Smoking Cessation |
| Bupropion | Adult | Outcome Assessment (Health Care) |
| Economics, Pharmaceutical | Male | Female |
Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.
Authors: Javitz HS, Swan GE, Zbikowski SM, Curry SJ, McAfee TA, Decker DL, Patterson R, Jack LM
Source: Am J Manag Care, 2004 Mar;10(3), p. 217-26.
PMID: 15032259
Related Citations
Grant Numbers:
| NCI NIH HHS - R01-CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
| Washington | Humans | Aged |
| Aged, 80 and over | Behavior Therapy | Delayed-Action Preparations |
| Cost-Benefit Analysis | Adult | Bupropion |
| Smoking Cessation | Middle Aged | Adolescent |
| Female | Male |
Heterogeneity in 12-month outcome among female and male smokers.
Authors: Swan GE, Javitz HS, Jack LM, Curry SJ, McAfee T
Source: Addiction, 2004 Feb;99(2), p. 237-50.
PMID: 14756716
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
| Dopamine Uptake Inhibitors | Sex Factors | Humans |
| Aged | Counseling | Smoking |
| Aged, 80 and over | Smoking Cessation | Adult |
| Bupropion | Treatment Outcome | Middle Aged |
| Adolescent | Female | Male |
Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
Authors: Swan GE, Jack LM, Curry S, Chorost M, Javitz H, McAfee T, Dacey S
Source: Nicotine Tob Res, 2003 Dec;5(6), p. 911-21.
PMID: 14668075
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
| Dopamine Uptake Inhibitors | Humans | Prognosis |
| Counseling | Delayed-Action Preparations | Nicotine |
| Risk Factors | Smoking Cessation | Adult |
| Bupropion | Ganglionic Stimulants | Middle Aged |
| Female | Male |
Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial.
Authors: Swan GE, McAfee T, Curry SJ, Jack LM, Javitz H, Dacey S, Bergman K
Source: Arch Intern Med, 2003 Oct 27;163(19), p. 2337-44.
PMID: 14581254
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 | NCI NIH HHS - R01 CA071358 |
MeSH Terms:
| Delayed-Action Preparations | Humans | Smoking Cessation |
| Bupropion | Adult | Treatment Outcome |
| Middle Aged | Male | Female |
Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting.
Authors: Jack LM, Swan GE, Thompson E, Curry SJ, McAfee T, Dacey S, Bergman K
Source: Prev Med, 2003 May;36(5), p. 585-93.
PMID: 12689804
Related Citations
Grant Numbers:
| NCI NIH HHS - CA71358 |
MeSH Terms:
| Dopamine Uptake Inhibitors | Washington | Humans |
| Patient Selection | Managed Care Programs | Adult |
| Bupropion | Smoking Cessation | Treatment Outcome |
| Interviews as Topic | Middle Aged | Female |
| Male |
A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins.
Authors: Li MD, Cheng R, Ma JZ, Swan GE
Source: Addiction, 2003 Jan;98(1), p. 23-31.
PMID: 12492752
Related Citations
Grant Numbers:
| NIDA NIH HHS - DA11170 | NCI NIH HHS - CA71358 | NIDA NIH HHS - DA12844 |
| NIDA NIH HHS - DA13783 |
MeSH Terms:
| Smoking | Twins | Sex Factors |
| Risk Factors | Humans | Adult |
| Environmental Exposure | Twin Studies as Topic | Male |
| Female |
